# Control of Major Bleeding After Trauma Study

> **NCT01838863** · PHASE2 · TERMINATED · sponsor: **Denver Health and Hospital Authority** · enrollment: 144 (actual)

## Conditions studied

- Trauma
- Hemorrhagic Shock

## Interventions

- **BIOLOGICAL:** Type AB plasma
- **DRUG:** Crystalloid fluid (standard of care for resuscitation)

## Key facts

- **NCT ID:** NCT01838863
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04-07
- **Primary completion:** 2017-04-03
- **Final completion:** 2017-04-03
- **Target enrollment:** 144 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838863, "Control of Major Bleeding After Trauma Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01838863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*